A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression
Condition(s):Depressive Disorder, Treatment-ResistantLast Updated:March 12, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Depressive Disorder, Treatment-ResistantLast Updated:March 12, 2024Completed
Condition(s):Treatment Resistant Depressive DisorderLast Updated:June 2, 2020Completed
Condition(s):Depressive Disorder, MajorLast Updated:May 3, 2023Completed
Condition(s):DepressionLast Updated:September 14, 2023Completed
Condition(s):Treatment-resistant DepressionLast Updated:May 4, 2020Completed
Condition(s):DepressionLast Updated:October 19, 2020Completed
Condition(s):Depressive Disorder, Treatment-ResistantLast Updated:November 26, 2019Withdrawn
Condition(s):Depressive Disorder, Treatment-ResistantLast Updated:May 24, 2022Completed
Condition(s):Depressive Disorder, MajorLast Updated:October 24, 2023Completed
Condition(s):Cancer PainLast Updated:October 19, 2023Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.